Biotechnology

BBB Access Route via Proteomic Vascular Mapping

Understanding the processes of molecular movement across the BBB has been somewh...

BIO Coffee Chat: Price controls like MFN harm access, i...

“Biotechnology innovation is advancing at an unprecedented pace, delivering new ...

Single-Cell Atlas of Maternal–Fetal Interface Sheds Lig...

Scientists mapped the human maternal–fetal interface in unprecedented detail, id...

Organ-on-Chip Integrated Into Preclinical Glioblastoma ...

Using Dynamic42’s human-based BBB-on-chip model, the partners will explore how d...

Scalable Embryonic Stem Cell Platform Enables Mitochond...

Researchers say the platform represents a strategically valuable foundation for ...

Neuroblastoma Tumor Growth in Mice Suppressed by Blocki...

Preclinical study showed that neuronal nitric oxide synthase drives neuroblastom...

Childhood Dementia Explained by Synaptic Dysfunction, O...

A new study uncovers how hyperactive and dysregulated synaptic circuits emerge i...

Plant Molecular Farming Comes of Age

The convergence of advances in biology and digital manufacturing is catapulting ...

Redefining Bioprocessing Using Reservoirs of Biochemica...

Scientists exploring Saudi Arabia’s desert soils have discovered resilient micro...

Faster Process Development via “Transfer Learning”

An emerging machine learning based technique called transfer learning has the po...

Forecasting Protein Aggregation with an Improved Algorithm

An algorithm for assessing protein aggregation and designing more soluble protei...

New Single‑Cell Platform Tracks RNA and Protein in Immu...

CIPHER‑seq is a single‑cell method that measures RNA and proteins simultaneously...

BIO expert: Future of biotech depends on competing with...

Ensuring a brighter future for U.S. biotech requires modernizing the Food and Dr...

Gilead to Acquire Tubulis for Up to $5B, Expanding Canc...

Headquartered in Munich, privately held Tubulis has developed next-generation AD...

High-Throughput Platform for Fast-Acting Covalent Prote...

Using this new platform, researchers developed a covalent antagonist targeting P...

Neurocrine Grows in Endocrinology, Rare Disease with $2...

Soleno finished 2025 with $190.4 million in net revenue from sales of Vykat. Neu...